SIGLEC12 and carcinoma: Upregulation of these well‐known oncogenic pathways in individuals with an intact SIGLEC12 allele may explain the molecular mechanisms underpinning our discovery of increased frequency of Siglec‐XII protein in advanced carcinomas.